BACKGROUND: Cardiac amyloidosis is a serious progressive disease with a high mortality rate. The differential diagnosis of cardiomyopathies due to amyloid light-chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis is important for selecting the optimal treatment strategy. AIM: The aim of this study was to evaluate the capabilities of cardiac magnetic resonance imaging in the di... https://www.incredibleindiatourtravels.com/